home / stock / inzy / inzy news

INZY News and Press, Inozyme Pharma Inc. From 11/07/23

Stock Information
Company Name: Inozyme Pharma Inc.
Stock Symbol: INZY
Market: NASDAQ
Website: inozyme.com
Menu
INZY INZY Quote INZY Short INZY News INZY Articles INZY Message Board
Get INZY Alerts

News, Short Squeeze, Breakout and More Instantly...
INZY - Inozyme Pharma GAAP EPS of -$0.29 beats by $0.03

2023-11-07 09:57:20 ET More on Inozyme Pharma Endpoints Unzipped: Inozyme's INZ-701 Twist In The Plot Seeking Alpha’s Quant Rating on Inozyme Pharma Historical earnings data for Inozyme Pharma Financial information for Inozyme Pharma For furthe...
INZY - Inozyme Pharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights

– Patient recruitment underway in ENERGY-3 Pivotal Trial of INZ-701 in pediatric patients with ENPP1 Deficiency; topline data expected mid-2025 – – Topline data readouts from ongoing Phase 1/2 trials of INZ-701 in adults with ABCC6 Deficiency and ENPP1 Deficiency ex...

INZY - SRPT, UPWK and TWOU are among after hour movers

2023-10-27 17:09:46 ET Gainers: Coherus BioSciences ( CHRS ) +16% . 2U ( TWOU ) +6% . Sarepta Therapeutics ( SRPT ) +5% . Noodles & Company ( NDLS ) +4% . Intuitive Machines ( LUNR ) +4% . Losers: NKGen Biotech ( NK...

INZY - Inozyme Pharma Announces Presentation at the American Society of Nephrology (ASN) Kidney Week 2023

BOSTON, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal prolifer...
INZY - CDNA, IDYA and INZY are among after hour movers

2023-10-23 17:42:52 ET Gainers: Redfin  ( RDFN ) +15% . Agilysys ( AGYS ) +11% . Medpace Holdings ( MEDP ) +5% . HomeStreet ( HMST ) +5% . IDEAYA Biosciences ( IDYA ) +5% . Losers: CareDx ( CDNA ) -8% . A...

INZY - SFIX, COMM and AMTX are among after hour movers

2023-10-11 17:30:06 ET Gainers: COMPASS Pathways  ( NASDAQ: CMPS ) +5% . Inozyme Pharma ( INZY ) +4% . CommScope Holding ( COMM ) +4% . FTAI Infrastructure ( FIP ) +3% . Aemetis ( AMTX ) +3% . Losers: Lottery ( ...

INZY - Inozyme Pharma Highlights Inclusion of Generalized Arterial Calcification of Infancy (GACI) in Genomics England's Generation Study of Rare Conditions

BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal prolifer...
INZY - Inozyme Pharma Announces Three Poster Presentations at the American Society for Bone and Mineral Research (ASBMR) 2023 Annual Meeting

BOSTON, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal prolifer...

INZY - Inozyme Pharma Announces Positive Interim Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE)

- Data from ongoing trial suggest clinical benefit for ENPP1 Deficiency, including improvement in key biomarkers, patient reported outcomes (PROs) and functional outcomes - - Improvement in the Global Impression of Change (GIC) observed in all three dose cohorts in ABCC6 Deficiency (PXE) tr...

INZY - Inozyme Pharma to Host Virtual Investor and Analyst Event on Sep. 26, 2023

BOSTON, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY)(“Inozyme” or the “Company”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferatio...
Previous 10 Next 10